Ultrasound-guided removal of Implanon devices.

Eur Radiol

Department of Radiology, The Adelaide and Meath Hospital, Tallaght, Dublin 24, Ireland.

Published: November 2008

Our study has shown that ultrasound-guided localisation and removal of Implanon rods is safe, practical and highly successful. Over a 4-year period, 119 patients had successful, uncomplicated removal of their subdermal devices.The technique is particularly useful for removal of the device when it is not palpable or when an attempt at removal of a palpable device has not been successful.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-008-1055-1DOI Listing

Publication Analysis

Top Keywords

removal implanon
8
ultrasound-guided removal
4
implanon devices
4
devices study
4
study ultrasound-guided
4
ultrasound-guided localisation
4
removal
4
localisation removal
4
implanon rods
4
rods safe
4

Similar Publications

We present a case of suspected induced intractable headaches and paralysis after receiving an etonogestrel 68 mg implant. After extensive neurological evaluation, the etonogestrel implant was removed and neurological symptoms resolved. The case raises concerns about a potential rare risk of progestin-containing contraceptives in patients with migraines with aura warranting further investigation.

View Article and Find Full Text PDF

Tips and tricks for the management of contraceptive etonogestrel implant in clinical practice: an Expert Opinion.

Eur J Contracept Reprod Health Care

December 2024

Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.

Article Synopsis
  • The global use of long-acting reversible contraceptives (LARCs) is rising because they more effectively prevent unintended pregnancies compared to short-acting methods, especially in teens.
  • LARCs include options like intrauterine devices and subcutaneous implants, with specialized training required for their application.
  • This Expert Opinion focuses on the etonogestrel (ENG)-releasing implant, offering updated guidance on insertion, removal, and managing unscheduled bleeding based on extensive clinical experience.
View Article and Find Full Text PDF

Introduction: Contraceptive discontinuation has become a widespread issue on a global basis. Implants, of which Implanon is the most popular, are only the second most widely used form of modern contraceptive in Ethiopia. However, Implanon was discontinued at a rate as high as 23.

View Article and Find Full Text PDF

Risk of early etonogestrel and levonorgestrel implant discontinuation in adolescents and adults.

BMC Public Health

November 2024

Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, 1873 Rama IV Road, Patum Wan, Patum Wan, Bangkok, 10330, Thailand.

Article Synopsis
  • Etonogestrel and levonorgestrel contraceptive implants are effective for 3 and 5 years, respectively, but early removal before due date can lead to unintended pregnancies, particularly among adolescents.
  • A study conducted at King Chulalongkorn Memorial Hospital analyzed early implant discontinuation from 2014 to 2019, finding a 19.3% overall discontinuation rate with intolerance to side effects, like abnormal bleeding, being the main reason for removal.
  • Results indicated that adolescents had a lower likelihood of early discontinuation than adults, with factors such as free implants, continuous use, postpartum status, and having children contributing to reduced discontinuation rates.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!